Dowling & Yahnke LLC Eli Lilly & CO Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dowling & Yahnke LLC holds 55,632 shares of LLY stock, worth $44.3 Million. This represents 8.37% of its overall portfolio holdings.

Number of Shares

55,632

Previous 55,669 0.07%

Holding current value

$44.3 Million

Previous $18.1 Million 0.34%

% of portfolio

8.37%

Previous 0.85%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $10,969 - $12,501	-37 Reduced 0.07%	55,632 $18 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $8,083 - $9,490	29 Added 0.05%	55,669 $18.1 Million
Q1 2022 May 04, 2022	SELL	$234.69 - $291.66 $89,651 - $111,414	-382 Reduced 0.68%	55,640 $15.9 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $143,679 - $178,306	-639 Reduced 1.13%	56,022 $15.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $66,480 - $81,813	-300 Reduced 0.53%	56,661 $13.1 Million
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $36,832 - $47,642	204 Added 0.36%	56,961 $13.1 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $57,019 - $73,813	-347 Reduced 0.61%	56,757 $10.6 Million
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $274,096 - $362,695	2,101 Added 3.82%	57,104 $9.64 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $227,079 - $262,658	-1,553 Reduced 2.75%	55,003 $8.14 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $227,548 - $273,852	-1,668 Reduced 2.86%	56,556 $9.29 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $276,672 - $342,441	-2,324 Reduced 3.84%	58,224 $8.08 Million
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $17,000 - $21,056	-159 Reduced 0.26%	60,548 $7.96 Million
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $116,401 - $126,614	1,090 Added 1.83%	60,707 $6.79 Million
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $43,208 - $50,434	390 Added 0.66%	59,617 $6.61 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $31,389 - $36,947	-282 Reduced 0.47%	59,227 $7.69 Million
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $63,540 - $71,184	600 Added 1.02%	59,509 $7.06 Million
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $58,384 - $72,970	-680 Reduced 1.14%	58,909 $6.32 Million
Q2 2018 Jul 30, 2018	BUY	$75.7 - $86.88 $13,550 - $15,551	179 Added 0.3%	59,589 $5.09 Million
Q1 2018 May 01, 2018	SELL	$74.21 - $87.6 $158,586 - $187,201	-2,137 Reduced 3.47%	59,410 $4.6 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $23,516 - $25,224	-287 Reduced 0.46%	61,547 $5.2 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $4.77 Million - $5.29 Million	61,834	61,834 $5.29 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Eli Lilly & CO Transaction History